Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.36 |
| ▸ | INPP5B | P32019 | 1/20 | 0.36 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | SRC | P12931 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10591882 | 0.80 | CTSB (0.37) | TDP1INPPL1INPP5ASRCGPR84 | |
| SCHEMBL36926 | 0.73 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| SCHEMBL2474284 | 0.73 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| SCHEMBL36925 | 0.73 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| SCHEMBL30679480 | 0.73 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| SCHEMBL2474283 | 0.73 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| SCHEMBL6041199 | 0.72 | CA1 (0.41) | ALDH1A1TDP1KDM4EHPGDHTT | |
| SCHEMBL23647344 | 0.71 | ALDH1A1 (0.55) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| Hydrochloric Acid SCHEMBL9614410 | 0.71 | ALDH1A1 (0.55) | ALDH1A1TDP1NPC1RECQLRAB9A | |
| Phosphoric Acid SCHEMBL8469920 | 0.71 | ALDH1A1 (0.55) | ALDH1A1TDP1NPC1RECQLRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119736370-A | Method for detecting universal light-operated CRISPR-Cas12a based on crRNA tail-added self-silencing strategy | 北京市农林科学院 | 2025-04-01 | — | — | CN | claimed |
| CN-118388957-A | Preparation method of nylon composite material for household appliance gasket | 浙江浩南精密电子有限公司 | 2024-07-26 | — | — | CN | claimed |
| EP-0642587-A4 | SYSTEM FOR MEASURING PROTEOLYTIC ACTIVITY OF PERIODONTOPATHOGENIC BACTERIA. | UNIV MICHIGAN (US) | 1997-03-19 | — | — | EP | claimed |
| EP-0642587-A1 | SYSTEM FOR MEASURING PROTEOLYTIC ACTIVITY OF PERIODONTOPATHOGENIC BACTERIA | THE UNIVERSITY OF MICHIGAN (US) | 1995-03-15 | — | — | EP | claimed |
| WO-1993024651-A1 | SYSTEM FOR MEASURING PROTEOLYTIC ACTIVITY OF PERIODONTOPATHOGENIC BACTERIA | UNIVERSITY OF MICHIGAN (US) | 1993-12-09 | — | — | WO | claimed |
| US-5116735-A | Colorimetric assay, hydrolysis of chromogen | THE UNIVERSITY OF MICHIGAN (US) | 1992-05-26 | — | — | US | claimed |
| EP-4733317-A2 | NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF | MedImmune, LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-3169407-B1 | NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF | MEDIMMUNE LLC (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12492240-B2 | Neutralizing anti-influenza A antibodies and uses thereof | MEDIMMUNE, LLC (US) | 2025-12-09 | — | — | US | disclosed |
| US-12487180-B2 | Device and methods for quantifying analytes introduction | Life Technologies Corporation (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250302952-A1 | METHOD OF TREATING INFLUENZA A | MEDIMMUNE, LLC | 2025-10-02 | — | — | US | disclosed |
| US-20250263470-A1 | NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF | MEDIMMUNE LLC (US) | 2025-08-21 | — | — | US | disclosed |
| US-12357692-B2 | Method of treating influenza A | MEDIMMUNE, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| EP-0431169-A1 | IMMUNOASSAY METHOD, REAGENT AND KIT | TEIJIN LIMITED (JP) | 1991-06-12 | — | — | EP | disclosed |
| EP-0423214-A1 | PURIFICATION AND ADMINISTRATION OF DNA REPAIR ENZYMES. | APPLIED GENETICS INC (US) | 1991-04-24 | — | — | EP | disclosed |
| EP-0410004-A1 | IMMUNOASSAY OF HUMAN OSTEOCALCIN, REAGENT AND KIT THEREFOR | TEIJIN LIMITED (JP) | 1991-01-30 | — | — | EP | disclosed |
| WO-1990000598-A1 | PURIFICATION AND ADMINISTRATION OF DNA REPAIR ENZYMES | APPLIED GENETICS, INC. (US) | 1990-01-25 | — | — | WO | disclosed |
| EP-0339504-A2 | Human immunodeficiency virus (HIV) env-coded peptide capable of eliciting HIV-inhibiting antibodies in mammals | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1989-11-02 | — | — | EP | disclosed |
| US-4517303-A | Specific binding assays utilizing analyte-cytolysin conjugates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-05-14 | — | — | US | disclosed |
| EP-0106370-A2 | Specific binding assays utilizing analyte-cytolysin conjugates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-04-25 | — | — | EP | disclosed |